In Q1 of 2019 CARE™ conducted a Needs Assessment on Mantle Cell Lymphoma (MCL) that was directed at hematologists/oncologists across Canada. The aim of this CARE™ program was to gather feedback on the current state of MCL management in Canada, while also identifying potential areas of need or gaps in knowledge.
This report is Wave 2 of follow-up to the CARE™ Needs Assessment on MCL and it focuses on front-line management.
This wave of follow-up features select response data from the CARE™ Needs Assessment on MCL along with a case study centered around a young, transplant eligible patient.
CARE™ Hematology Faculty who have contributed to this report:
Dr. Diego Villa (BC Cancer)